Found 88 matching trials
SIRT With Tremelimumab and Durvalumab for Resectable HCC PHASE1 The goal of this research study is to evaluate the safety and tolerability ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Defining the Ablative Dose for Y-90 TARE PHASE2 This study is being done to help doctors improve how they treat liver tumor...
Show More Location
Northwestern University
Learn More & Join Trial
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer PHASE1 This clinical trial will be conducted as a single-center, open-label, Phase...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases PHASE1 This is a phase I dose escalation study (3+3 design) with a dose expansion ...
Show More Location
University of California San Francisco
Learn More & Join Trial
Streamlining Radioembolization for Small HCC N/A In patients who has no sign suggesting high lung shunt fraction (TIPS, hepa...
Show More Location
National Cancer Center
Learn More & Join Trial
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres PHASE2 Neuroendocrine tumors (NETs) and cancers that originate from the gastrointe...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial
Same-day Radioembolization for Large HCC N/A In patients who has no sign suggesting high lung shunt fraction (TIPS, hepa...
Show More Location
National Cancer Center
Learn More & Join Trial
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial PHASE1 This phase I/II trial tests the safety, side effects and effectiveness of r...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia NA Evaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for ...
Show More Location
Northwestern University/Northwestern Memorial Hospital
Learn More & Join Trial
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases PHASE2 This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Show More Location
University of California, San Francisco
Learn More & Join Trial